Biological TherapyProton TherapyRadiotherapy Planning, Computer-AssistedPhysical Therapy ModalitiesBiological ProductsRadiotherapy DosageRadiometryFilm DosimetryRadiation InjuriesRadiation DosageRadiotherapy, Intensity-ModulatedRadiotherapy, ConformalRadiation, IonizingAntirheumatic AgentsTreatment OutcomeDose-Response Relationship, RadiationRadiation ToleranceAntineoplastic AgentsRadiotherapyRadiationArthritis, RheumatoidRadiation ProtectionRadiation OncologyCombined Modality TherapyAntibodies, MonoclonalRadiation MonitoringGenetic TherapyNeoplasmsPhantoms, ImagingTime FactorsPhenetidinePsoriasisArthritis, PsoriaticAntibodies, Monoclonal, HumanizedDose FractionationImmunologic FactorsDermatologic AgentsRadiotherapy, AdjuvantRadiation PneumonitisBrachytherapySpondylarthritisCell Line, TumorReceptors, Tumor Necrosis FactorRadiation-Sensitizing AgentsNeoplasms, Radiation-InducedRadiation Injuries, ExperimentalClinical Trials as TopicAntibodies, Monoclonal, Murine-DerivedRheumatic DiseasesRadiosurgeryGamma RaysTumor Necrosis Factor-alphaDrug Screening Assays, AntitumorCosmic RadiationOff-Label UseSchizophrenia, CatatonicRadiotherapy, Computer-AssistedAntineoplastic Combined Chemotherapy ProtocolsRetrospective StudiesBrain NeoplasmsAnti-Inflammatory AgentsCisplatinDoxorubicinGastrointestinal AgentsCranial IrradiationApoptosisParticle AcceleratorsImmunotherapyNeoplasm Recurrence, LocalRadiotherapy, Image-GuidedInflammatory Bowel DiseasesCrohn DiseaseHead and Neck NeoplasmsRadiation-Protective AgentsCell SurvivalBackground RadiationRadiodermatitisBreast NeoplasmsImmunoglobulin GMethotrexateRadiotherapy, High-EnergyImmunosuppressive AgentsPrognosisImmunoconjugatesUltraviolet RaysNeoplasm StagingOrgans at RiskDNA DamageModels, BiologicalCobalt RadioisotopesProstatic NeoplasmsRadiation EffectsAntineoplastic Agents, PhytogenicDrug Resistance, NeoplasmCarcinoma, Squamous CellChemoradiotherapyRadiobiologyAdenocarcinomaTumor Cells, CulturedSurvival Analysis